SCHEMBL7974267

SCHEMBL7974267

Oc1nc(-c2ccncc2)nc2ncn(Cc3cccc(Cl)c3)c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.43
GLA P06280 1/20 0.43
HTT P42858 1/20 0.43
UBE2N P61088 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ACP1 P24666 1/20 0.41
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
HTR6 P50406 2/20 0.40
YTHDC1 Q96MU7 3/20 0.40
IDO1 P14902 1/20 0.39
PRKCI P41743 1/20 0.39
EGLN1 Q9GZT9 1/20 0.39
MET P08581 1/20 0.37
FSCN1 Q16658 1/20 0.37
KDM4E B2RXH2 2/20 0.37
MEN1 O00255 1/20 0.37
HPGD P15428 1/20 0.37
KMT2A Q03164 1/20 0.37
CNR2 P34972 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988668 0.91 SMN1; SMN2 (0.44) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7973626 0.90 SMN1; SMN2 (0.45) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7974441 0.89 GRK2 (0.43) SMN1; SMN2CYP11B1CYP11B2HTR6HPGD
SCHEMBL7988659 0.89 P2RX7 (0.41) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7988817 0.88 SMN1; SMN2 (0.43) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7991646 0.87 SMN1; SMN2 (0.43) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7988747 0.87 CYP11B1 (0.44) SMN1; SMN2HTTCYP11B1CYP11B2MET
SCHEMBL7985264 0.87 CYP11B1 (0.41) CYP11B1CYP11B2METHPGDROCK2
SCHEMBL7991566 0.86 ACP1 (0.43) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7974012 0.85 ALDH1A1 (0.41) SMN1; SMN2GLAHTTUBE2NL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed